NLRP3 deletion inhibits inflammation-driven mouse lung tumorigenesis induced by benzo(a)pyrene and lipopolysaccharide

被引:34
|
作者
Huang, Li [1 ]
Duan, Shuyin [1 ]
Shao, Hua [1 ]
Zhang, Aihua [3 ]
Chen, Shuang [4 ]
Zhang, Peng [2 ]
Wang, Na [1 ]
Wang, Wei [1 ]
Wu, Yongjun [1 ]
Wang, Jing [5 ]
Liu, Hong [5 ]
Yao, Wu [1 ]
Zhang, Qiao [1 ]
Feng, Feifei [1 ]
机构
[1] Zhengzhou Univ, Dept Toxicol, Coll Publ Hlth, 100 Kexue Ave, Zhengzhou 450001, Henan, Peoples R China
[2] Zhengzhou Univ, Affiliated Canc Hosp, Dept Bone & Soft Tissue Canc, Henan Canc Hosp, Zhengzhou, Henan, Peoples R China
[3] Nanjing Med Univ, Dept Nephrol, Childrens Hosp, Nanjing, Jiangsu, Peoples R China
[4] Nanjing Med Univ, Inst Pediat, Nanjing, Jiangsu, Peoples R China
[5] Zhengzhou Univ, Affiliated Hosp 1, Dept Pulm Med, Zhengzhou, Henan, Peoples R China
基金
中国国家自然科学基金;
关键词
Benzo(a)pyrene; Lipopolysaccharide; Lung tumorigenesis; Inflammation; NLRP3; NF-KAPPA-B; CANCER; EXPOSURE; INJURY; MODELS; MICE;
D O I
10.1186/s12931-019-0983-4
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
BackgroundInflammatory micro-environment has been proposed to play a critical role in lung tumorigenesis. NLRP3 is known as an intracellular receptor involving inflammation and has been reported which is increasingly associated with tumor development, but the role in inflammation-driven lung cancer has not been fully clarified. In this study, we investigated whether lipopolysaccharide (LPS)-induced pulmonary inflammation could contribute to lung tumorigenesis induced by benzo(a)pyrene [B(a)p] in C57BL/6J mice and the role of NLRP3 in the pathogenesis.MethodsNLRP3-/- mice and C57BL/6J mice (wide-type, WT) were instilled intratracheally with B(a)p (1mg/mouse) once a week for 4 times [the week of the last time of B(a)p treatment named Week 0], and mice were then instilled intratracheally with LPS at Week 3, 2.5g/mouse, once every three weeks for 5 times. At Week 30, the incidence, number, size and histopathology of lung tumor were analyzed.ResultsMice exposed to B(a)p or B(a)p plus LPS could induce lung tumors, whereas LPS or vehicles treatment could not induce lung tumorigenesis. In WT mice, B(a)p plus LPS exposure significantly increased tumor incidence, mean tumor count and tumor size of visible tumors of lungs compared with B(a)p treatment alone, and NLRP3 deletion inhibited lung tumorigenesis induced by B(a)p or B(a)p plus LPS. Histopathological examination found LPS-induced pulmonary inflammatory changes enhanced lung tumorigenesis induced by B(a)p in WT mice, deletion of NLRP3 improved the inflammatory changes induced by LPS and the number and size of pathological tumor nests induced by B(a)p or B(a)p plus LPS. In addition, we found B(a)p treatment and B(a)p plus LPS treatment predominately induced the development of adenoma.ConclusionLPS enhanced B(a)p-induced lung tumorigenesis in WT and NLRP3-/- mice of C57BL/6J strain, and NLRP3 deletion inhibits lung tumorigenesis induced by B(a)p or B(a)p plus LPS.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] MiR-20b inhibits mycobacterium tuberculosis induced inflammation in the lung of mice through targeting NLRP3
    Lou, Jun
    Wang, Yongli
    Zhang, Zhimin
    Qiu, Weiqiang
    EXPERIMENTAL CELL RESEARCH, 2017, 358 (02) : 120 - 128
  • [22] Mefloquine targets NLRP3 to reduce lipopolysaccharide-induced systemic inflammation and neural injury
    Jiang, Si-Yuan
    Tian, Tian
    Li, Wen-Jie
    Liu, Ting
    Wang, Cong
    Hu, Gang
    Du, Ren-Hong
    Liu, Yang
    Lu, Ming
    EMBO REPORTS, 2023,
  • [23] Global deletion of NLRP3 limits silicainduced inflammation and fibrosis in acute and chronic mouse models of silicosis
    Lam, M.
    Barry, K.
    Hodges, C.
    Harpur, C.
    Mansell, A.
    Tate, M.
    RESPIROLOGY, 2024, 29 : 205 - 205
  • [24] Beetroot red (betanin) inhibits vinyl carbamate- and benzo(a)pyrene-induced lung tumorigenesis through apoptosis
    Zhang, Qi
    Pan, Jing
    Wang, Yian
    Lubet, Ronald
    You, Ming
    MOLECULAR CARCINOGENESIS, 2013, 52 (09) : 686 - 691
  • [25] Mangiferin Mitigates Lipopolysaccharide-Induced Lung Injury by Inhibiting NLRP3 Inflammasome Activation
    Li, Ning
    Xiong, Rui
    He, Ruyuan
    Liu, Bohao
    Wang, Bo
    Geng, Qing
    JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 2289 - 2300
  • [26] Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation
    Li, Yi
    Li, Haitao
    Liu, Shuai
    Pan, Pinhua
    Su, Xiaoli
    Tan, Hongyi
    Wu, Dongdong
    Zhang, Lemeng
    Song, Chao
    Dai, Minhui
    Li, Qian
    Mao, Zhi
    Long, Yuan
    Hu, Yongbin
    Hu, Chengping
    MOLECULAR IMMUNOLOGY, 2018, 99 : 134 - 144
  • [27] The preventive role of the red gingeng ginsenoside Rg3 in the treatment of lung tumorigenesis induced by benzo(a)pyrene
    Xiong, Jie
    Yuan, Hongmei
    Fei, Shihong
    Yang, Shengli
    You, Ming
    Liu, Li
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [28] The preventive role of the red gingeng ginsenoside Rg3 in the treatment of lung tumorigenesis induced by benzo(a)pyrene
    Jie Xiong
    Hongmei Yuan
    Shihong Fei
    Shengli Yang
    Ming You
    Li Liu
    Scientific Reports, 13 (1)
  • [29] Aloperine alleviates lipopolysaccharide-induced acute lung injury by inhibiting NLRP3 inflammasome activation
    Zeng, Jie
    Liu, Jie
    Huang, Jun-Hao
    Fu, Shao-Ping
    Wang, Xin-Yi
    Xi, Chao
    Cui, Yan-Ru
    Qu, Fei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 120
  • [30] PRAVASTATIN ENHANCES THE NLRP3 INFLAMMASOME ACTIVATION AND DETERIORATES BLEOMYCIN INDUCED LUNG INFLAMMATION AND FIBROSIS
    Xu, J-F
    Nakahira, K.
    Lee, S-J
    Patel, A. S.
    Li, H-P
    Qu, J-M
    Morse, D.
    Ryter, S. W.
    Choi, A. M. K.
    RESPIROLOGY, 2011, 16 : 314 - 314